ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,599Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 434

$513K Total Retail Price of All Prescriptions

Rank: 38 out of 434

420 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 420 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 8,196 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 631 497 1 1
LEVOTHYROXINE SODIUM 518 404 2 3
HYDROCODONE-ACETAMINOPHEN 478 274 S3 3 4
AMLODIPINE BESYLATE 447 351 4 6
PRAVASTATIN SODIUM 349 232 5 17
METFORMIN HCL 307 230 6 7
SIMVASTATIN 295 248 7 2
METOPROLOL TARTRATE 261 205 8 12
LOVASTATIN 252 234 9 10
FUROSEMIDE 245 176 10 9
OMEPRAZOLE 229 134 11 5
POTASSIUM CHLORIDE 183 146 12 20
MELOXICAM 178 146 13 46
WARFARIN SODIUM 153 142 14 18
DONEPEZIL HCL 153 150 14 35
CARISOPRODOL 147 38 R 16 44
RANITIDINE HCL 130 98 17 31
TAMSULOSIN HCL 125 99 18 29
CLONIDINE HCL 125 101 18 63
NAMENDA 125 124 18 72
TRIAMTERENE-HCTZ 123 93 21 47
CEPHALEXIN 117 61 22 119
FAMOTIDINE 117 106 22 76
ZOLPIDEM TARTRATE 115 75 24 11
CITALOPRAM HBR 111 76 25 23
GABAPENTIN 111 61 25 14
HYDRALAZINE HCL 110 80 27 79
HYDROCHLOROTHIAZIDE 109 91 28 8
CARVEDILOL 108 85 29 24
GLYBURIDE 101 92 R 30 51
OXYCODONE HCL-ACETAMINOPHEN 100 56 S2 31 53
GEMFIBROZIL 98 65 32 62
ATENOLOL 97 70 33 16
VERAPAMIL ER 89 64 34 78
DIVALPROEX SODIUM 88 62 35 111
ISOSORBIDE MONONITRATE ER 87 81 36 68
RISPERIDONE 84 47 37 87
GLIPIZIDE ER 84 35 37 65
CLOPIDOGREL 80 58 39 41
CIPROFLOXACIN HCL 77 43 40 55
LOSARTAN POTASSIUM 67 43 41 13
MIRTAZAPINE 66 45 42 97
SERTRALINE HCL 65 38 43 27
QUETIAPINE FUMARATE 64 28 44 128
ALENDRONATE SODIUM 64 56 44 15
JANTOVEN 62 50 46 161
GLIPIZIDE 61 38 47 37
TRAZODONE HCL 61 0 47 33
SPIRIVA 61 49 47 36
PROVENTIL HFA 59 37 50 179
FENOFIBRATE 56 11 51 43
METOPROLOL SUCCINATE 56 47 51 22
NIFEDIPINE ER 54 44 53 86
AMIODARONE HCL 51 41 54 153
KLOR-CON M20 50 29 55 142
ALLOPURINOL 50 47 55 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.